The Blood Management RFID Tags ecosystem spans upstream component supply, midstream tag assembly and system integration, and downstream deployment within clinical and transfusion facilities. Upstream, raw material and component suppliers deliver RFID chips, antennas, and biocompatible substrates. Midstream actors—including technology developers, OEM manufacturers, and system integrators—transform these inputs into compliant, read‑write tags and embed them within blood collection kits and inventory platforms. Downstream, distributors channel finished tags to hospitals, blood banks, and transfusion services, where they generate value by enabling real‑time traceability, inventory optimization, and regulatory compliance. Value is captured through hardware sales, licensing of encoding protocols, and recurring service contracts.